Medtronic Cardiac Ablation Solutions
Clinical trials sponsored by Medtronic Cardiac Ablation Solutions, explained in plain language.
Division of Medtronic making devices for cardiac ablation procedures.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart device registry tracks Real-World results for 1,950 AFib patients Results expected Oct 2026 (estimated)
- New heart catheter aims to stop dangerous rhythms in their tracks Results expected Nov 2026 (estimated)
- New catheter aims to tame irregular heartbeat Results expected Mar 2027 (estimated)
- New device aims to zap away atrial fibrillation Results expected Mar 2027 (estimated)
- New heart procedure tracked for 3 years in 580 patients Results expected Apr 2027 (estimated)
-
New heart tool aims to stop AFib Flare-Ups
Disease control OngoingThis study tests a new device that uses heat to destroy tiny areas in the heart causing short bursts of irregular heartbeat (paroxysmal atrial fibrillation). About 300 adults with this condition will receive the procedure and be monitored for a year. The goal is to see if the tre…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Freezing away heart flutters: new study tests Long-Term control of persistent AF
Disease control OngoingThis study looks at a procedure called cryoablation that uses a freezing balloon to destroy tiny areas of heart tissue causing an irregular heartbeat (persistent atrial fibrillation). About 400 adults with this condition will be followed for up to 3 years to see how well the trea…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New heart ablation device under scrutiny for persistent AF
Disease control OngoingThis study follows 200 adults with persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year) who are treated with the Sphere-9 catheter and Affera ablation system. The goal is to see how safe the procedure is and how well it prev…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart device DiamondTemp under Real-World watch: will it deliver?
Knowledge-focused OngoingThis registry follows 545 people with arrhythmia who received a heart ablation using the DiamondTemp system. Researchers will track how many stay free of their heart rhythm problem and how many have serious side effects over 12 months. The goal is to see how well the device works…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC